These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27256982)

  • 1. Altered splicing leads to reduced activation of CPEB3 in high-grade gliomas.
    Skubal M; Gielen GH; Waha A; Gessi M; Kaczmarczyk L; Seifert G; Freihoff D; Freihoff J; Pietsch T; Simon M; Theis M; Steinhäuser C; Waha A
    Oncotarget; 2016 Jul; 7(27):41898-41912. PubMed ID: 27256982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Phosphospecific Antibody Reveals Isoform-Specific Phosphorylation of CPEB3 Protein.
    Kaczmarczyk L; Labrie-Dion É; Sehgal K; Sylvester M; Skubal M; Josten M; Steinhäuser C; De Koninck P; Theis M
    PLoS One; 2016; 11(2):e0150000. PubMed ID: 26915047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the transcripts and protein isoforms for cytoplasmic polyadenylation element binding protein-3 (CPEB3) in the mouse retina.
    Wang XP; Cooper NG
    BMC Mol Biol; 2009 Dec; 10():109. PubMed ID: 20003455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma.
    Xiaoping L; Zhibin Y; Wenjuan L; Zeyou W; Gang X; Zhaohui L; Ying Z; Minghua W; Guiyuan L
    Cell Death Dis; 2013 Jun; 4(6):e675. PubMed ID: 23788032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.
    Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L
    Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas.
    Restrepo A; Smith CA; Agnihotri S; Shekarforoush M; Kongkham PN; Seol HJ; Northcott P; Rutka JT
    Neuro Oncol; 2011 Jan; 13(1):42-50. PubMed ID: 21075782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPEB1 regulates the expression of MTDH/AEG-1 and glioblastoma cell migration.
    Kochanek DM; Wells DG
    Mol Cancer Res; 2013 Feb; 11(2):149-60. PubMed ID: 23360795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
    Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
    Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of IL-8 gene expression in gliomas by microRNA miR-93.
    Fabbri E; Brognara E; Montagner G; Ghimenton C; Eccher A; Cantù C; Khalil S; Bezzerri V; Provezza L; Bianchi N; Finotti A; Borgatti M; Moretto G; Chilosi M; Cabrini G; Gambari R
    BMC Cancer; 2015 Oct; 15():661. PubMed ID: 26449498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade.
    Teng Y; Dong YC; Liu Z; Zou Y; Xie H; Zhao Y; Su J; Cao F; Jin H; Ren H
    Int J Mol Med; 2017 Mar; 39(3):725-733. PubMed ID: 28204824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
    Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
    J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of centrosomal proteins at different stages of human glioma.
    Loh JK; Lieu AS; Chou CH; Lin FY; Wu CH; Howng SL; Chio CC; Hong YR
    BMC Cancer; 2010 Jun; 10():268. PubMed ID: 20529377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.
    Mueller S; Phillips J; Onar-Thomas A; Romero E; Zheng S; Wiencke JK; McBride SM; Cowdrey C; Prados MD; Weiss WA; Berger MS; Gupta N; Haas-Kogan DA
    Neuro Oncol; 2012 Sep; 14(9):1146-52. PubMed ID: 22753230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas.
    Song SW; Fuller GN; Zheng H; Zhang W
    Cancer Res; 2005 May; 65(9):3562-7. PubMed ID: 15867349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
    Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
    Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.
    Gömöri E; Pál J; Kovács B; Dóczi T
    Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
    Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
    Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
    Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
    Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.